BeyondSpring CEO: China's New System Will Get Our Drug To Market Faster

 
• By Sten Stovall

The US/Chinese biotech expects speedier approval of its lead asset plinabulin in China thanks to the government's new drug approval policy.

US & China
BeyondSpring Hopes To Straddle US And China Drug Markets • Source: Shutterstock

More from Strategy

More from Business